Additionally, we initially explored the underlying mechanisms in ccRCC by which the Caf.Sig model could forecast the ICI efficacy, specifically, by iCAFs communicating with CD8+ Tex cells. The gene discussed is CD8A; the disease is nonpapillary renal cell carcinoma.